TABLE 2.
Prevalences of VF genes in FQREC and FQSEC
| Resistance group and case typea (nb) | No. (%) of isolates with indicated genec
|
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adhesin gene
|
Iron uptake gene
|
Toxin gene
|
Cell protection gene
|
Other
|
||||||||||||||
| afa | fimH | iha | pap | sfa/foc | aer | fyuA | iroN | cnf1 | hly | cvaC | kpsMT | ompT | traT | ibeA | PAI | usp | ETTT | |
| FQREC | ||||||||||||||||||
| UC (38) | 6 (16) | 38 (100) | 32 (84) | 12 (32) | 0 | 33 (87) | 34 (89) | 2 (5.3) | 0 | 4 (11) | 0 | 31 (82) | 32 (84) | 28 (74) | 2 (5.3) | 25 (66) | 21 (55) | 21 (55) |
| CC (51) | 2 (3.9) | 49 (96) | 27 (53) | 10 (20) | 1 (2.0) | 43 (84) | 42 (82) | 5 (9.8) | 0 | 3 (5.9) | 4 (7.8) | 35 (69) | 31 (61) | 38 (75) | 3 (5.9) | 34 (67) | 27 (53) | 26 (51) |
| Total (89) | 8 (9.0) | 87 (98) | 59 (66) a | 22 (25) | 1 (1.1) a | 76 (85) a | 76 (85) | 7 (7.9) b | 0 a | 7 (7.9) a | 4 (4.5) | 66 (74) d | 63 (71) d | 66 (74) | 5 (5.6) a | 59 (66) | 48 (54) a | 47 (53) a |
| FQSEC | ||||||||||||||||||
| UC (38) | 4 (11) | 37 (97) | 12 (32) | 17 (45) | 8 (21) | 15 (40) | 37 (97) | 11 (29) | 12 (32) | 12 (32) | 5 (13) | 36 (95) | 34 (90) | 33 (87) | 17 (45) | 30 (79) | 32 (84) | 5 (13) |
| CC (51) | 4 (7.8) | 50 (98) | 14 (28) | 15 (29) | 13 (25) | 17 (33) | 44 (86) | 17 (33) | 14 (27) | 17 (33) | 4 (7.8) | 44 (86) | 43 (84) | 35 (69) | 16 (31) | 40 (78) | 41 (80) | 9 (18) |
| Total (89) | 8 (9.0) | 87 (98) | 26 (29) | 32 (36) | 21 (24) | 32 (36) | 81 (91) | 28 (32) | 26 (29) | 29 (33) | 9 (10) | 80 (90) | 77 (87) | 68 (76) | 33 (37) | 70 (79) | 73 (82) | 14 (16) |
a
UC, uncomplicated cystitis; CC, complicated cystitis.
b
n, no. of isolates.
c
Letters indicate P values for results for FQREC versus those for FQSEC: a, P < 0.0001; b, P < 0.001; c, P < 0.01; d, P < 0.05.